Expanding Long COVID care and education for underserved communities
Long COVID Care Resources and Education to Advance Community Health (REACH)
A Stanford-led Long COVID hub will work with community health centers to bring coordinated care, education, and specialist support to people with lingering COVID symptoms in underserved areas.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11194999 on NIH RePORTER |
What this research studies
You would be helped by a team-based Long COVID hub that partners with local federally qualified health centers (FQHCs) to share expertise and resources. The program provides patient and clinician education, peer-to-peer support for primary care providers, and real-time consultation with specialists. It focuses on reaching low-income patients and communities of color by strengthening care and referral pathways at safety-net clinics. The goal is to make diagnosis, treatment plans, and ongoing support easier to get where you already receive care.
Who could benefit from this research
Good fit: Ideal candidates are people with persistent symptoms after COVID-19, especially patients who receive care at participating community health centers or safety-net clinics.
Not a fit: People without post-COVID symptoms or those who do not receive care from the program's partner clinics are unlikely to get direct benefit from this effort.
Why it matters
Potential benefit: If successful, this could improve access to diagnosis, coordinated treatment, and ongoing support for people with Long COVID in underserved communities.
How similar studies have performed: Multidisciplinary Long COVID clinics at major centers have helped many patients, but extending that hub-and-spoke model to safety-net FQHC networks is a newer, less-tested approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Geng, Linda N — Stanford University
- Study coordinator: Geng, Linda N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.